Genomic Vision propose des solutions fondées sur
l’analyse structurale de l’ADN et des tests génétiques
dans les domaines du cancer, des maladies héréditaires
rares et de la pharmaco-génomique.
Director of Business Development
Sébastien Barradeau received his PhD in genetics and molecular biology from the University of Paris VII and the Institut Pasteur, Paris. He joined Genomic Vision as Project Leader in 2008 after eight years in different pharmaceuticals companies (Aventis, ObeTherapy Biotechnology and Genfit) where his work mainly focused in new target identification and validation as well as in early drug development. Since July 2014, he leads the Research and Product Development (RPD) Department at Genomic Vision.